Log In
BCIQ
Print this Print this
 

SAGE-689

  Manage Alerts
Collapse Summary General Information
Company Sage Therapeutics Inc.
Description 
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationSeizures
Indication DetailsAdjunctive therapy for status epilepticus
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today